Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today that Geoff Green, Chief Executive Officer at Longeveron, will present at the upcoming Q1 Virtual Investor Summit on Tuesday, March 8, 2022. Details of Longeveron’s participation follow below:
Format: Virtual Company Presentation
Date: Tuesday, March 8, 2022
Time: 2:00 - 2:30 p.m. ET
A live webcast will be available via the Investors & Media section of the Company website (www.longeveron.com). Following the presentation, an archived replay will be available on Longeveron’s website.
https://finance.yahoo.com/news/longeveron-present-q1-virtual-investor-130000720.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.